Published Online
on December 19, 2005

A more recent version of this article appeared on March 1, 2006

This Article Full Text (PDF) All Versions of this Article: 47/3/590    most recent 01.HYP.0000196945.73586.0dv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorrance, A. M. Articles by Nogueira, E. F. Search for Related Content PubMed PubMed Citation Articles by Dorrance, A. M. Articles by Nogueira, E. F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB POTASSIUM Related Collections Remodeling Cerebrovascular disease/stroke Pathology of Stroke Risk Factors for Stroke

Submitted on September 20, 2005
Revised on October 12, 2005

Mineralocorticoid Receptor Activation Causes Cerebral Vessel Remodeling and Exacerbates the Damage Caused by Cerebral Ischemia

Anne M. Dorrance^*; Nikki C. Rupp; and Edson F. Nogueira

From the Department of Physiology, Medical College of Georgia, Augusta, Ga.

^* To whom correspondence should be addressed. E-mail: adorrance{at}.mcg.edu.

Abstract--Mineralocorticoid receptor antagonists protect against ischemic cerebrovascular disease; this appears to be caused by changes in cerebral vessel structure that would promote blood flow. Therefore, we hypothesized that mineralocorticoid receptor activation with deoxycorticosterone acetate would cause deleterious remodeling of the cerebral vasculature and exacerbate the damage caused by cerebral ischemia. Six-week-old male Wistar rats were treated with deoxycorticosterone acetate (200 mg/kg) for 6 weeks. At 12 weeks of age, the deoxycorticosterone acetate-treated rats had elevated systolic blood pressure compared with age-matched controls (157±5.9 versus 124±3.1 mm Hg deoxycorticosterone acetate versus control; P<0.05). The area of ischemic damage resulting from middle cerebral artery occlusion was greater in the deoxycorticosterone acetate-treated rats than control (63.5±3.72 versus 46.6±5.52% of the hemisphere infarcted, deoxycorticosterone acetate versus control; P<0.05). Middle cerebral artery structure was assessed using a pressurized arteriograph under calcium-free conditions. Over a range of intralumenal pressures, the lumen and ODs of the middle cerebral arteries were smaller in the deoxycorticosterone acetate-treated rats than the control rats (P<0.05). There was also an increase in the wall thickness and wall:lumen ratio in the vessels from deoxycorticosterone acetate-treated rats (P<0.05). The vessels from the deoxycorticosterone acetate-treated rats were stiffer than those from control rats as evidenced by a leftward shift in the stress/strain curve. These novel data suggest that mineralocorticoid receptor activation without salt loading and nephrectomy is sufficient to elicit deleterious effects on the cerebral vasculature that lead to inward hypertrophic remodeling and an increase in the ischemic damage in the event of a stroke.

Key words: mineralocorticoids • cerebral ischemia • remodeling • cerebral arteries • aldosterone

This article has been cited by other articles:

				F. Jimenez-Altayo, L. Caracuel, F. J. Perez-Asensio, S. Martinez-Revelles, A. Messeguer, A. M. Planas, and E. Vila Participation of Oxidative Stress on Rat Middle Cerebral Artery Changes Induced by Focal Cerebral Ischemia: Beneficial Effects of 3,4-Dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6) J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 429 - 436. [Abstract] [Full Text] [PDF]

				Y. Tada, K. T. Kitazato, T. Tamura, K. Yagi, K. Shimada, T. Kinouchi, J. Satomi, and S. Nagahiro Role of Mineralocorticoid Receptor on Experimental Cerebral Aneurysms in Rats Hypertension, September 1, 2009; 54(3): 552 - 557. [Abstract] [Full Text] [PDF]

				L. A. Martinez-Lemus, M. A. Hill, and G. A. Meininger The Plastic Nature of the Vascular Wall: A Continuum of Remodeling Events Contributing to Control of Arteriolar Diameter and Structure Physiology, February 1, 2009; 24(1): 45 - 57. [Abstract] [Full Text] [PDF]

				J. M. Osmond and A. M. Dorrance 11{beta}-Hydroxysteroid Dehydrogenase Type II Inhibition Causes Cerebrovascular Remodeling and Increases Infarct Size after Cerebral Ischemia Endocrinology, February 1, 2009; 150(2): 713 - 719. [Abstract] [Full Text] [PDF]

				N. Oyamada, M. Sone, K. Miyashita, K. Park, D. Taura, M. Inuzuka, T. Sonoyama, H. Tsujimoto, Y. Fukunaga, N. Tamura, et al. The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia Endocrinology, August 1, 2008; 149(8): 3764 - 3777. [Abstract] [Full Text] [PDF]

				C. S. Rigsby, A. E. Burch, S. Ogbi, D. M. Pollock, and A. M. Dorrance Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1754 - R1763. [Abstract] [Full Text] [PDF]